The ROE as of September 2024 (TTM) for Anixa Biosciences, Inc. (ANIX) is -52.41%

According to Anixa Biosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -52.41%. This represents a change of 298.41% compared to the average of -13.16% of the last 4 quarters.

Anixa Biosciences, Inc. (ANIX) Historical ROE (quarterly & annually)

How has ANIX ROE performed in the past?

The mean historical ROE of Anixa Biosciences, Inc. over the last ten years is -156.37%. The current -52.41% ROE has changed -66.48% with respect to the historical average. Over the past ten years (40 quarters), ANIX's ROE was at its highest in in the January 2015 quarter at 45.44%. The ROE was at its lowest in in the October 2016 quarter at -106.10%.

Anixa Biosciences, Inc. (ANIX) ROE by Quarter and Year

Discovering the peaks and valleys of Anixa Biosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Anixa Biosciences, Inc. (ANIX) Average ROE

How has ANIX ROE performed in the past?

The current ROE of Anixa Biosciences, Inc. (ANIX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Anixa Biosciences, Inc. (ANIX) ROE vs. Peers

How is ANIX’s ROE compared to its peers?

Anixa Biosciences, Inc.’s ROE is greater than Cue Biopharma, Inc. (-142.93%), greater than INmune Bio, Inc. (-101.34%), greater than IN8bio, Inc. (-173.12%), greater than PolyPid Ltd. (-969.85%), greater than TFF Pharmaceuticals, Inc. (-225.16%), greater than Immunome, Inc. (-157.86%), less than Annovis Bio, Inc. (2.78%), greater than Aerovate Therapeutics, Inc. (-83.65%), greater than Adagene Inc. (-63.48%), greater than Acrivon Therapeutics, Inc. Common Stock (-47.31%), greater than Rezolute, Inc. (-60.90%), greater than AN2 Therapeutics, Inc. (-54.72%), greater than Anebulo Pharmaceuticals, Inc. (-122.97%), greater than Mineralys Therapeutics, Inc. (-42.61%), greater than Arcellx, Inc. (-12.42%), greater than PMV Pharmaceuticals, Inc. (-21.96%), greater than Molecular Partners AG (-33.08%),

Build a custom stock screener for Anixa Biosciences, Inc. (ANIX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anixa Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Anixa Biosciences, Inc. (ANIX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Anixa Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.